CHANDA ANDERSON: Open Payments
NPI 1508401548 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 57 payments from 17 companies in 2025. Trend: 2023 $564 · 2024 $634 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $229 |
| PFIZER INC. | 11 | $138 |
| Novo Nordisk Inc | 5 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Merck Sharp & Dohme LLC | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Lundbeck LLC | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: UBRELVY, PREVNAR 20, QULIPTA, NURTEC ODT, Wegovy, REXULTI, CAPLYTA, VRAYLAR.
Industry payments across NE — which companies pay providers there.
